Hercules Capital, Inc.
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Hercules Capital, Inc. (NYSE: HTGC) is a business development company (BDC) that provides venture lending and growth capital to innovative, high-growth companies, primarily in technology, life sciences, and sustainable/renewable technology-enabled sectors. The company offers a diversified portfolio of customized financing solutions, including senior secured loans; unitranche loans; mezzanine debt; equity investments; and warrant and equity-related securities, often structured as first- and second-lien loans with warrants for upside participation. Hercules targets late-stage venture-backed companies and underserved middle-market firms, operating principally in the United States with a focus on U.S.-based portfolio companies across software, internet, healthcare, and clean tech industries. Founded in 2003 and headquartered in Palo Alto, California, Hercules Capital manages approximately $4 billion in assets under management as of late 2025, serving as a leading non-bank lender to the venture ecosystem. The company structures its investments to provide flexible capital for growth initiatives such as mergers and acquisitions, product development, and international expansion, while maintaining rigorous due diligence and active portfolio management. It operates through subsidiaries like Hercules Capital Funding I, LLC, and has no parent company, functioning as an independent publicly traded BDC regulated under the Investment Company Act of 1940. In recent developments, Hercules Capital completed several strategic portfolio expansions in 2024 and 2025, including new debt and equity investments in high-profile tech firms such as those in AI infrastructure and biotech, bolstering its portfolio diversification amid rising interest rates. The company announced a key partnership with leading venture capital firms in Q3 2025 to co-invest in Series D and later-stage companies, enhancing deal flow and risk mitigation. Additionally, Hercules raised capital through an at-the-market equity offering program in early 2025, funding over $300 million in new originations and supporting dividend sustainability with a payout ratio under 90%.
Company News
Hercules Capital (NYSE:HTGC) Stock Crosses Above 200 Day Moving Average – Time to Sell?
Hercules Capital: This Juicy 11.5% Yield Is On Sale
Hercules Capital Receives Affirmed BBB- Investment Grade Corporate and Unsecured Credit Rating from Fitch Ratings, Inc.
Hercules Capital (HTGC) Exceeds Market Returns: Some Facts to Consider
Hercules Capital Announces Date for Release of Third Quarter 2026 Financial Results and Conference Call
4 Stocks Yielding Up to 12% That Income Investors Can Own Today
The Roth IRA Mistake That Turns $4,450 a Month in Tax-Free Dividends Into a Tax Bill
Three Income Buckets, $9,750 a Month, and a Portfolio That Never Has to Sell a Share
Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors
Hercules Capital Closes Institutional Notes Offering of $400.0 Million 6.700% Notes due 2029
The Roth IRA Advantage: How Much More These High-Yield Dividend Stocks Pay Tax Free
Rocket Pharmaceuticals Secures Strategic Credit Facility for Up to $150 Million from Hercules Capital
Hercules Capital Prices Upsized Institutional Notes Offering of $400.0 Million 6.70% Notes due 2029
Comparing LPL Financial (NASDAQ:LPLA) and Hercules Capital (NYSE:HTGC)
How Much Does a 69-Year-Old Need Invested to Collect $8,250 a Month for Life?
Investing $50,000 Each in These 4 Dividend Stocks Spins off $18,000 a Year in Passive Income
Hercules Capital (HTGC) Stock Sinks As Market Gains: Here's Why
How Much Do You Need Invested to Collect $8,450 a Month for Life?
Want $8,000 in Passive Income? Invest $25,000 in Each of These 4 Dividend Stocks
NorthStar Secures Up to $185 Million Growth Financing Led by Hercules Capital to Scale Actinium-225 Production and Radiopharmaceutical Manufacturing for Next-Generation Precision Cancer Therapies